Wellstat Therapeutics Corporation is a privately-held biopharmaceutical company located in Gaithersburg, Maryland. Dedicated to the discovery, development and commercialization of innovative therapeutics that expand the frontiers of medicine, Wellstat Therapeutics Corporation is committed to improving the lives of patients with chronic and life-threatening diseases.\nWellstat Therapeutics's focus is in the following fields:\nOncology\nMetabolic Diseases\nNeurodegenerative Diseases\nNeurometabolic Diseases\nWellstat Therapeutics is developing an extensive and diverse pipeline of novel small molecule therapeutic agents. The Company owns a broad patent portfolio covering this technology and is constantly expanding its intellectual property estate. Wellstat Therapeutics' pipeline spans the stages of development from discovery through Phase III clinical trials.\nWellstat Therapeutics was founded in 1985. The Company has a highly talented management team with significant experience in drug discovery, development, and commercialization. Samuel J. Wohlstadter, a company founder and the Chief Executive Officer was also a founder of Amgen Inc., Applied Biosystems (currently a division of Applera Corporation), IGEN International Inc. (currently a subsidiary of Roche), BioVeris Corporation (currently a subsidiary of Roche), and Hyperion Catalysis International, Inc.\nWellstat Therapeutics employs dedicated scientists, business professionals and support personnel at its state-of-the-art facilities in Gaithersburg, Maryland. Wellstat Therapeutics is part of the Wellstat Group of Companies, one of the largest and leading bioscience employers in the Baltimore-Washington Metropolitan Area. The Wellstat Group of Companies has expertise in all stages of discovery research and development, including:\nChemistry\nCell and Molecular Biology\nDisease Models\nTranslational Biology\nClinical Research and Development\nProject Management\nRegulatory Quality Assurance and Control\nManufacturing\nLegal and Financial

Interleukin Genetics, Inc. is a genetics-focused personalized health company that develops genetic tests for sale to the emerging personalized health market. Their vision is to build a leading personalized health and wellness company. They believe that the science of applied genetics can empower individuals to personalize their health and provide valuable information to assist in drug development. They currently have two primary focus areas to their business. The first is personalized health, which is primarily focused on providing genetic test products to customers. These products are distributed via sales partners and their own sales channels, with the goal of providing guidance for the individual interested in improving their health and wellness. The second is a research and development effort focused on developing genetic tests linked to a partner’s products for marketing and sales into medical and dental channels. Both areas contribute toward their overall mission of providing products that can help individuals improve and maintain their health through preventive measures.

Spectral Medical, Inc. engages in the development and commercialization of therapeutic treatment for septic shock. Its products include endotoxin activity assay diagnostic and polymyxin b-hemoperfusion therapeutic device. The company was founded on July 29, 1991 and is headquartered in Toronto, Canada.

Alnylam is the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare genetic, cardio-metabolic, hepatic infectious, and central nervous system (CNS)/ocular diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach for the treatment of a wide range of severe and debilitating diseases.

Elder Pharmaceuticals Ltd. manufactures and sells pharmaceuticals bulk drugs and formulations. It deals with pharmaceuticals and related products, which manufactures and markets prescription pharmaceutical brands, surgical and medical devices. The company was founded by Jagdish Kantiswarup Saxena on April 2, 1983 and is headquartered in Mumbai, India.

Forest Laboratories, Inc. is engaged in the development, manufacture, and sale of branded forms of drug products. Its products include Bystolic, which is used to decrease heart rate and myocardial contractility; Daliresp, which is used to reduce the risk of chronic obstructive pulmonary disease exacerbation; Linzess, which is used in the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation; and Namenda, which is used in the treatment of moderate to severe dementia. The company was founded in 1954 and is headquartered in New York, NY.

sigma-tau is one of the most important Italian pharmaceutical groups, with a major presence also on the international stage. For more than half a century the company has been active in promoting the quality of life of man and his health. sigma-tau is present today in the most advanced research sectors, maintaining constant relations with scientific institutions with a world-wide reputation in the development of joint projects and in the implementation of original and innovative research programs. These results are the fruit of substantial, ongoing investment in research in the field of pharmaceutical innovation and stem not only from the efforts made to produce new products but also from the success of the company’s consolidated products. Bearing witness to sigma-tau’s achievements are not only the principles and values that inspire our efforts - innovation, dialogue and transparency, ethics, sustainability - but also the facts that have made sigma-tau a leading company in the research, manufacture and marketing of drugs.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

COPAN Systems, Inc. was founded in 2002 by a team of experienced executives from leading storage and technology companies with a vision of creating products that are purpose built for managing the unique requirements of long-term persistent data.\nAs the leader in leveraging the full power of MAID (Massive Array of Idle Disks) technology at the enterprise level its solutions are based on a patented Enterprise MAID architecture that delivers massive scalability and performance with unprecedented affordability.\nCOPAN Systems is privately held company with investment backing by Austin Ventures, Credit Suisse, Globespan Capital Partners, Gold Hill Capital, NTT Leasing Capital (USA), FirstMark Capital, and Presidio STX.

Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. It creates multiple products on the market and a development pipeline. The company became a member of the Roche Group in 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech’s South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech’s Research and Early Development section operates as an independent center within Roche. Genentech was founded in 1976 by [Robert Swanson](https://www.crunchbase.com/person/robert-a-swanson) and [Herbert Boyer](https://www.crunchbase.com/person/herbert-w-boyer). It is headquartered in South San Francisco, C.A.

Sol-Gel Technologies Ltd. is a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T. The company was founded by David Avnir and Alon Seri-Levy on October 28, 1997 and is headquartered in Ness Ziona, Israel.

Ellipsis Biotherapeutics Corp., a subsidiary of DNAPrint Genomics, Inc., is a Canadian company located in Toronto, ON. The firm provides commercial genotyping services and gene research. It was acquired by DNAPrint Genomics, Inc. on December 19, 2005 for $0.11 million.

Athena Diagnostics, Inc. provides clinical diagnostics testing laboratory services. The firm focuses on neurology, endocrinology, hearing loss and nephrology. It offers tests for Alzheimer's disease, muscular dystrophy and other neuromuscular and developmental disorders. The company was founded in 1988 and is headquartered in Marlborough, MA.

Celera Corp. provides medical diagnostics services. It offers disease management solutions through a combination of tests and services based on genetics discovery platforms. Celera was founded in 1998 and is headquartered in Alameda, CA.

Zambon SpA is engaged in manufacturing pharmaceutical products. It offers anauran, anaurette, asacol, codex, fluimucil, and giason. The company is headquartered in Bresso, Italy.

BL Technology, Inc. provides control system integration services. Its systems include control panel, instrumentation, security systems, PLC/HMI equipment, programming services, system integration, fire alarm systems, intrusion alarm sound reinforcement and video analytics. The firm serves municipalities, government, educational facilities, water/wastewater, petrochemical, oil & gas, subsea, power & energy, and material handling industries. The company was founded by Robert Beese and Robert M. Lee in 1974 and is headquartered in Tomball, TX.

Nexus Dx, Inc. engages in the provision of of a near patient testing system and advanced diagnostic solution. Its offers point-of-care (POC) immunoassay, IB10 analyzer system, and tests for established critical care parameters. The company was founded on January 16, 2009 and is headquartered in San Diego, CA.